Skip to main content
XCUR
NASDAQ Life Sciences

Major Shareholder Exicure HiTron Inc. Sells $3.3M in Shares, Reducing Stake to 29.2%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$6.14
Mkt Cap
$39.136M
52W Low
$3.101
52W High
$15.91
52W Position info
98% above low
Off High info
61% below high
Rel. Volume
Market data snapshot near publication time

XCUR sits 98% above its 52-week low of $3.101.

Summary

Exicure HiTron Inc., a major shareholder, sold 734,747 shares of Exicure, Inc. for $3.3 million, reducing its beneficial ownership to 29.2%.


Key Events · Ownership and Investor Activity · XCUR

  • Significant Share Transfer

    Exicure HiTron Inc. transferred 734,747 shares of common stock on January 16, 2026.

  • Substantial Proceeds

    The shares were sold at $4.50 per share, generating aggregate proceeds of $3,306,361.5.

  • Reduced Ownership Stake

    Following the transfer, Exicure HiTron Inc.'s beneficial ownership decreased to 1,857,314 shares, representing approximately 29.2% of the outstanding common stock.

  • Below Market Price Sale

    The sale price of $4.50 per share is below the current stock price of $6.14.


Analysis · XCUR · Life Sciences

Exicure HiTron Inc., a significant corporate shareholder, has substantially reduced its stake in Exicure, Inc. by transferring over 734,000 shares for approximately $3.3 million. This transaction represents a notable portion of the company's market capitalization and a significant reduction in the reporting person's holdings. The sale price of $4.50 per share is below the current market price of $6.14, which could be interpreted negatively by investors. This move by a major corporate investor may signal a shift in their investment strategy or a need for liquidity, potentially creating an overhang on the stock.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XCUR was trading at $6.14 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $39.1M. The 52-week trading range was $3.10 to $15.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XCUR - Latest Insights

XCUR
Nov 10, 2026, 3:50 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.01 info
Change: -$0.071 (-7%) info
Market Cap: $7.07M info
XCUR
Nov 10, 2026, 3:50 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.01 info
Change: -$0.071 (-7%) info
Market Cap: $7.07M info
XCUR
Nov 02, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $1.01 info
Change: -$0.050 (-5%) info
Market Cap: $7.07M info
XCUR
Sep 16, 2026, 10:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $1.01 info
Change: -$0.295 (-23%) info
Market Cap: $7.07M info
XCUR
Aug 14, 2026, 3:27 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $1.01 info
Change: -$0.250 (-20%) info
Market Cap: $7.07M info